RxDoctor Payments DataLook up a doctor →

Kofi Quist, MD

Neurology with Special Qualifications in Child Neurology · Indianapolis, INNPI 1295933349

Payments from drug & device makers

$17,828in general payments, 2019–2025

Across 823 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$2K
  • UCB, Inc.$2K
  • Jazz Pharmaceuticals Inc.$2K
  • AbbVie$1K
  • Biogen$809
  • Lilly USA, LLC$704
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Livanova USA, Inc.22$2,461
UCB, Inc.120$2,095
Jazz Pharmaceuticals Inc.55$1,640
AbbVie(2 entities)87$1,340
Biogen39$809
Lilly USA, LLC55$704
Teva Pharmaceuticals USA, Inc.40$629
Pfizer48$566
Neurelis, Inc.19$565
Amgen17$512
Catalyst Pharmaceuticals, Inc.23$496
SK Life Science, Inc.17$477
Greenwich Biosciences, Inc.12$358
Novartis21$350
Sunovion Pharmaceuticals Inc.32$306
Eisai Inc.18$298
Neurocrine Biosciences, Inc.12$255
Axsome Therapeutics, Inc.9$245
Lundbeck LLC9$220
Argenx US, Inc.7$219
AstraZeneca6$194
Takeda Pharmaceuticals U.S.A., Inc.9$183
Banner Life Sciences, LLC9$169
Biohaven Pharmaceutical Holding Company Ltd.12$160
Supernus Pharmaceuticals, Inc.10$159
Alnylam Pharmaceuticals Inc.6$142
Harmony Biosciences LLC5$142
Mallinckrodt Hospital Products Inc.3$134
Sumitomo Pharma America, Inc.7$133
Genentech USA, Inc.6$129
Vanda Pharmaceuticals Inc.7$126
Grifols USA, LLC5$101
Biocodex, Inc.1$100
Avanir Pharmaceuticals, Inc.5$98
EMD Serono, Inc.5$89
MDD US Operations, LLC5$85
Octapharma USA, Inc.4$81
Amneal Pharmaceuticals LLC5$80
Sanofi4$76
Cycle Pharmaceuticals Inc3$61
ANI Pharmaceuticals, Inc.2$60
Acorda Therapeutics, Inc3$58
Abbott3$50
Johnson & Johnson2$48
Impel Pharmaceuticals Inc.2$48
Aprecia Pharmaceuticals, LLC3$45
Ipsen Biopharmaceuticals, Inc3$43
Medtronic3$42
Azurity Pharmaceuticals, Inc.2$42
PTC Therapeutics, Inc.2$40
Inspire Medical Systems, Inc.1$37
TG Therapeutics, Inc.2$36
Otsuka America Pharmaceutical, Inc.2$36
Avadel CNS Pharmaceuticals, LLC1$28
Tanabe Pharma America, Inc.1$26
Springworks Therapeutics, Inc.1$26
Biohaven Pharmaceuticals, Inc.1$23
Aquestive Therapeutics, Inc.1$20
Upsher-smith Laboratories LLC1$18
Acadia Pharmaceuticals Inc1$18

How this compares

$17,828 in reported general payments places this provider in the 75th percentile of 25 neurology with special qualifications in child neurology providers in Indiana.

See all neurology with special qualifications in child neurology providers in Indiana →

Medicare billing

Part B allowed, 2024
$567,834
Medicare patients
91
Services billed
12,065

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology with special qualifications in child neurology in Indianapolis

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →